Brind.

AstraZeneca released a press release citing Dr. Frank Sciurba.

6 reports, 2 independent Updated Sep 21

Gone quiet Reached 4 outlets in its first 24 hours

Reports: 6
Developments: 2
Repetition: 67%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

AstraZeneca released a press release citing Dr. Frank Sciurba.

Who's involved

What this event is mainly about

AstraZeneca Frank Sciurba

How it developed

Newest first. Tap a step to see who reported it.

Sep 8AstraZeneca cited Dr. Sciurba in a recent press release.1 source
- abcnews.com
Sep 8Sciurba is appointed Chief Investigator of the LUNA programme.1 source
- miragenews.com

Keep exploring

The entities involved

AstraZeneca
British-Swedish pharmaceutical company
- AstraZeneca's trial failure has created a competitive advantage for Alnylam Pharmaceuticals, which is leveraging AI in its commercial execution.Mon 11:04
- Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.Sat 18:52
Frank Sciurba
researcher

Nothing else this week.

Related events

Coverage

Newest first; wire copies grouped

Sep 8abcnews.com
Sep 8miragenews.com

4 more outlets ran the same wire story